1 Flu Vaccination Market Overview

• 1.1 Product Overview and Scope of Flu Vaccination
• 1.2 Flu Vaccination Segment by Type
• 1.2.1 Global Flu Vaccination Sales Growth Rate Comparison by Type (2022-2028)

1.2.2 Trivalent Influenza Vaccine

1.2.3 Quadrivalent Influenza Vaccine

1.3 Flu Vaccination Segment by Application

1.3.1 Global Flu Vaccination Sales Comparison by Application: (2022-2028)

1.3.2 6 Months to 3 Years

1.3.3 Above 3 Years

1.4 Global Flu Vaccination Market Size Estimates and Forecasts

1.4.1 Global Flu Vaccination Revenue 2017-2028

1.4.2 Global Flu Vaccination Sales 2017-2028

1.4.3 Flu Vaccination Market Size by Region: 2017 Versus 2021 Versus 2028

2 Flu Vaccination Market Competition by Manufacturers

• 2.1 Global Flu Vaccination Sales Market Share by Manufacturers (2017-2022)
• 2.2 Global Flu Vaccination Revenue Market Share by Manufacturers (2017-2022)
• 2.3 Global Flu Vaccination Average Price by Manufacturers (2017-2022)
• 2.4 Manufacturers Flu Vaccination Manufacturing Sites, Area Served, Product Type
• 2.5 Flu Vaccination Market Competitive Situation and Trends
• 2.5.1 Flu Vaccination Market Concentration Rate

2.5.2 The Global Top 5 and Top 10 Largest Flu Vaccination Players Market Share by Revenue

2.5.3 Global Flu Vaccination Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Flu Vaccination Retrospective Market Scenario by Region

• 3.1 Global Flu Vaccination Retrospective Market Scenario in Sales by Region: 2017-2022
• 3.2 Global Flu Vaccination Retrospective Market Scenario in Revenue by Region: 2017-2022
• 3.3 North America Flu Vaccination Market Facts & Figures by Country
• 3.3.1 North America Flu Vaccination Sales by Country

3.3.2 North America Flu Vaccination Revenue by Country

3.3.3 United States

3.3.4 Canada

3.4 Europe Flu Vaccination Market Facts & Figures by Country

3.4.1 Europe Flu Vaccination Sales by Country

3.4.2 Europe Flu Vaccination Revenue by Country

3.4.3 Germany

3.4.4 France

3.4.5 U.K.

3.4.6 Italy

3.4.7 Russia

3.5 Asia Pacific Flu Vaccination Market Facts & Figures by Region

3.5.1 Asia Pacific Flu Vaccination Sales by Region

3.5.2 Asia Pacific Flu Vaccination Revenue by Region

3.5.3 China

3.5.4 Japan

3.5.5 South Korea

3.5.6 India

3.5.7 Australia

3.5.8 China Taiwan

3.5.9 Indonesia

3.5.10 Thailand

3.5.11 Malaysia

3.6 Latin America Flu Vaccination Market Facts & Figures by Country

3.6.1 Latin America Flu Vaccination Sales by Country

3.6.2 Latin America Flu Vaccination Revenue by Country

3.6.3 Mexico

3.6.4 Brazil

3.6.5 Argentina

3.7 Middle East and Africa Flu Vaccination Market Facts & Figures by Country

3.7.1 Middle East and Africa Flu Vaccination Sales by Country

3.7.2 Middle East and Africa Flu Vaccination Revenue by Country

3.7.3 Turkey

3.7.4 Saudi Arabia

3.7.5 UAE

4 Global Flu Vaccination Historic Market Analysis by Type

• 4.1 Global Flu Vaccination Sales Market Share by Type (2017-2022)
• 4.2 Global Flu Vaccination Revenue Market Share by Type (2017-2022)
• 4.3 Global Flu Vaccination Price by Type (2017-2022)

5 Global Flu Vaccination Historic Market Analysis by Application

• 5.1 Global Flu Vaccination Sales Market Share by Application (2017-2022)
• 5.2 Global Flu Vaccination Revenue Market Share by Application (2017-2022)
• 5.3 Global Flu Vaccination Price by Application (2017-2022)

6 Key Companies Profiled

• 6.1 Sanofi
• 6.1.1 Sanofi Corporation Information

6.1.2 Sanofi Description and Business Overview

6.1.3 Sanofi Flu Vaccination Sales, Revenue and Gross Margin (2017-2022)

6.1.4 Sanofi Flu Vaccination Product Portfolio

6.1.5 Sanofi Recent Developments/Updates

6.2 CSL

6.2.1 CSL Corporation Information

6.2.2 CSL Description and Business Overview

6.2.3 CSL Flu Vaccination Sales, Revenue and Gross Margin (2017-2022)

6.2.4 CSL Flu Vaccination Product Portfolio

6.2.5 CSL Recent Developments/Updates

6.3 GSK

6.3.1 GSK Corporation Information

6.3.2 GSK Description and Business Overview

6.3.3 GSK Flu Vaccination Sales, Revenue and Gross Margin (2017-2022)

6.3.4 GSK Flu Vaccination Product Portfolio

6.3.5 GSK Recent Developments/Updates

6.4 Viatris

6.4.1 Viatris Corporation Information

6.4.2 Viatris Description and Business Overview

6.4.3 Viatris Flu Vaccination Sales, Revenue and Gross Margin (2017-2022)

6.4.4 Viatris Flu Vaccination Product Portfolio

6.4.5 Viatris Recent Developments/Updates

6.5 AstraZeneca

6.5.1 AstraZeneca Corporation Information

6.5.2 AstraZeneca Description and Business Overview

6.5.3 AstraZeneca Flu Vaccination Sales, Revenue and Gross Margin (2017-2022)

6.5.4 AstraZeneca Flu Vaccination Product Portfolio

6.5.5 AstraZeneca Recent Developments/Updates

6.6 Hualan Bio

6.6.1 Hualan Bio Corporation Information

6.6.2 Hualan Bio Description and Business Overview

6.6.3 Hualan Bio Flu Vaccination Sales, Revenue and Gross Margin (2017-2022)

6.6.4 Hualan Bio Flu Vaccination Product Portfolio

6.6.5 Hualan Bio Recent Developments/Updates

6.7 Changchun Institute of Biological

6.6.1 Changchun Institute of Biological Corporation Information

6.6.2 Changchun Institute of Biological Description and Business Overview

6.6.3 Changchun Institute of Biological Flu Vaccination Sales, Revenue and Gross Margin (2017-2022)

6.4.4 Changchun Institute of Biological Flu Vaccination Product Portfolio

6.7.5 Changchun Institute of Biological Recent Developments/Updates

6.8 Sinovac

6.8.1 Sinovac Corporation Information

6.8.2 Sinovac Description and Business Overview

6.8.3 Sinovac Flu Vaccination Sales, Revenue and Gross Margin (2017-2022)

6.8.4 Sinovac Flu Vaccination Product Portfolio

6.8.5 Sinovac Recent Developments/Updates

6.9 BCHT

6.9.1 BCHT Corporation Information

6.9.2 BCHT Description and Business Overview

6.9.3 BCHT Flu Vaccination Sales, Revenue and Gross Margin (2017-2022)

6.9.4 BCHT Flu Vaccination Product Portfolio

6.9.5 BCHT Recent Developments/Updates

6.10 Jiangsu GDK

6.10.1 Jiangsu GDK Corporation Information

6.10.2 Jiangsu GDK Description and Business Overview

6.10.3 Jiangsu GDK Flu Vaccination Sales, Revenue and Gross Margin (2017-2022)

6.10.4 Jiangsu GDK Flu Vaccination Product Portfolio

6.10.5 Jiangsu GDK Recent Developments/Updates

6.11 KM Biologics

6.11.1 KM Biologics Corporation Information

6.11.2 KM Biologics Flu Vaccination Description and Business Overview

6.11.3 KM Biologics Flu Vaccination Sales, Revenue and Gross Margin (2017-2022)

6.11.4 KM Biologics Flu Vaccination Product Portfolio

6.11.5 KM Biologics Recent Developments/Updates

7 Flu Vaccination Manufacturing Cost Analysis

• 7.1 Flu Vaccination Key Raw Materials Analysis
• 7.1.1 Key Raw Materials

7.1.2 Key Suppliers of Raw Materials

7.2 Proportion of Manufacturing Cost Structure

7.3 Manufacturing Process Analysis of Flu Vaccination

7.4 Flu Vaccination Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

• 8.1 Marketing Channel
• 8.2 Flu Vaccination Distributors List
• 8.3 Flu Vaccination Customers

9 Flu Vaccination Market Dynamics

• 9.1 Flu Vaccination Industry Trends
• 9.2 Flu Vaccination Market Drivers
• 9.3 Flu Vaccination Market Challenges
• 9.4 Flu Vaccination Market Restraints

10 Global Market Forecast

• 10.1 Flu Vaccination Market Estimates and Projections by Type
• 10.1.1 Global Forecasted Sales of Flu Vaccination by Type (2023-2028)

10.1.2 Global Forecasted Revenue of Flu Vaccination by Type (2023-2028)

10.2 Flu Vaccination Market Estimates and Projections by Application

10.2.1 Global Forecasted Sales of Flu Vaccination by Application (2023-2028)

10.2.2 Global Forecasted Revenue of Flu Vaccination by Application (2023-2028)

10.3 Flu Vaccination Market Estimates and Projections by Region

10.3.1 Global Forecasted Sales of Flu Vaccination by Region (2023-2028)

10.3.2 Global Forecasted Revenue of Flu Vaccination by Region (2023-2028)

11 Research Finding and Conclusion

12 Methodology and Data Source

• 12.1 Methodology/Research Approach
• 12.1.1 Research Programs/Design

12.1.2 Market Size Estimation

12.1.3 Market Breakdown and Data Triangulation

12.2 Data Source

12.2.1 Secondary Sources

12.2.2 Primary Sources

12.3 Author List

Influenza vaccines, also known as flu shots, are vaccines that protect against influenza. A new version of the vaccine is developed twice a year as the influenza virus rapidly changes. Most provide modest to high protection against influenza; however, each year this varies. Evidence in adults over 65 years old is poor. They decrease the number of missed days of work by a half day on average. Vaccinating children may protect those around them.
Industry Insights

Due to the COVID-19 pandemic, the global Flu Vaccination market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, the Europe Flu Vaccination market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %, and it is predicted that China market share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe Flu Vaccination landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.

Trivalent Influenza Vaccine accounting for % of the Flu Vaccination global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While 6 Months to 3 Years segment is altered to an % CAGR throughout this forecast period and will hold a share about % in 2028.

The global major manufacturers of Flu Vaccination include Sanofi, CSL, GSK, Viatris, AstraZeneca, Hualan Bio, Changchun Institute of Biological, Sinovac and BCHT, etc. In terms of revenue, the global 3 largest players have a % market share of Flu Vaccination in 2021.

This report focuses on Flu Vaccination volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall Flu Vaccination market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan, etc.

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Post-covid-19 Outlook

The readers in the section will understand how the Flu Vaccination market scenario changed across the globe during the pandemic and post-pandemic. The study is done keeping in view the changes in aspects such as sales, demand and supply chain. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Segmental Outlook

Key segments including type and application have been elaborated in this report. The consultants at QY Research have studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows sales and revenue data by type, and application during the historical period (2017-2022) and forecast period (2023-2028).

Segment by Type

Trivalent Influenza Vaccine

Quadrivalent Influenza Vaccine

Segment by Application

6 Months to 3 Years

Above 3 Years

Regional Outlook

This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue and sales data of each region and country for the period 2017-2028. This information derived through comprehensive research will help the reader to get familiar with the potential value of the investment in a particular region.

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Russia

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Indonesia

Thailand

Malaysia

Latin America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Competitive Scenario

In this section, the readers will gain an understanding of the key players competing. The experts at QY Research have studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:

Sanofi

CSL

GSK

Viatris

AstraZeneca

Hualan Bio

Changchun Institute of Biological

Sinovac

BCHT

Jiangsu GDK

KM Biologics

Frequently Asked Questions

Which product segment grabbed the largest share in the Flu Vaccination market?

How is the competitive scenario of the Flu Vaccination market?

Which are the key factors aiding the Flu Vaccination market growth?

Which are the prominent players in the Flu Vaccination market?

Which region holds the maximum share in the Flu Vaccination market?

What will be the CAGR of the Flu Vaccination market during the forecast period?

Which application segment emerged as the leading segment in the Flu Vaccination market?

What key trends are likely to emerge in the Flu Vaccination market in the coming years?

What will be the Flu Vaccination market size by 2028?

Which company held the largest share in the Flu Vaccination market?